Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Inv. Zdp 29 Regulatory News (EJFZ)

Share Price Information for Ejf Inv. Zdp 29 (EJFZ)

Share Price is delayed by 15 minutes
Get Live Data
109.50    0.00 (0.00%)
Bid:
108.00
Ask:
111.00
Spread: 3.00 (2.778%)
Market Cap: -
EJFZ Live PriceLast checked at - London Stock Exchange

Intraday Ejf Inv. Zdp 29 Share Chart

Issue of Equity

15 Sep 2025 16:42

RNS Number : 3959Z
EJF Investments Ltd
15 September 2025
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

Β 

Β 

15 September 2025

Β 

Β 

EJF Investments Limited (the "Company")

Β 

Issue of Equity

The Company announces that it has today issued 150,000 of its 2029 zero dividend preference shares ("ZDP Shares") pursuant to its block listing facility. The ZDP Shares will be issued at a price of 102.8102 pence.

Following the issue of ZDP Shares, the Company's issued 2029 ZDP share capital will comprise of 18,501,593 ZDP Shares.

Β 

ENQUIRIES

For the Investment Manager

EJF Investments Manager LLC

Mungo Hargreaves / Jay Ghatalia

MHargreaves@ejfcap.com / jghatalia@ejfcap.com

+44 20 3752 6775 / +44 203 752 6776

Β 

For the Company Secretary and Administrator

Apex Financial Services (Alternative Funds) LimitedΒ 

ejficosec@apexgroup.comΒ 

+44 204 549 0721Β 

Β 

For the Broker

Panmure Liberum Limited

Darren Vickers / Ashwin Kohli

+44 203 100 2222

Β 

About EJF Investments Limited

EJFI's objective is to provide shareholders with attractive risk adjusted returns through regular dividends and capital growth over the long term. EJFI generates exposure primarily to a diversified portfolio of loans issued by financial institutions and related or similar assets in the U.S., U.K. and Europe.

Β 

EJFI currently invests primarily in CDO Equity Tranches structured by an affiliate of EJF Capital LLC, providing levered exposure to a highly diversified portfolio of securities issued by U.S. financial institutions (banks and insurance companies), these being Risk Retention Investments.

Β 

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

Β 

LEI:Β 549300XZYEQCLA1ZAT25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEFLFSEAIIELIE
Date   Source Headline
29th May 20264:18 pmRNSTotal Voting Rights
28th May 20265:24 pmRNSIssue of Equity
27th May 20264:29 pmRNSRecent Investment Announcement
22nd May 20267:00 amRNSNet Asset Value and Portfolio Update
21st May 20265:00 pmRNSManager Reinvestment in EJFI Shares
21st May 20265:00 pmRNSDirector/PDMR Shareholding
12th May 20268:32 amRNSQuarterly Report
11th May 20265:15 pmRNSIssue of Equity
30th Apr 20264:19 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSDividend Declaration
23rd Apr 20264:47 pmRNSIssue of Equity
23rd Apr 20267:00 amRNSNet Asset Value and Portfolio Update
10th Apr 20264:49 pmRNSIssue of Equity
9th Apr 20265:27 pmRNSIssue of Equity
31st Mar 20264:53 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSAnnouncement of Final Results to 31 December 2025
20th Mar 20267:00 amRNSNet Asset Value and Portfolio Update
16th Mar 20264:35 pmRNSNotice of Annual Results & Investor Presentations
12th Mar 20265:19 pmRNSIssue of Equity
3rd Mar 20265:08 pmRNSRecent Investment Announcement
27th Feb 20265:37 pmRNSTotal Voting Rights
27th Feb 20263:32 pmRNSCompliance with Market Abuse Regulation
27th Feb 202611:59 amRNSQuarterly Report
25th Feb 20265:20 pmRNSIssue of Equity
24th Feb 20267:00 amRNSBlock Listing Application
20th Feb 20267:00 amRNSNet Asset Value and Portfolio Update
11th Feb 20264:22 pmRNSIssue of Equity
9th Feb 202611:01 amRNSDirector/PDMR Shareholding
9th Feb 202610:33 amRNSManager Reinvestment in EJFI Shares
3rd Feb 20265:27 pmRNSIssue of Equity
30th Jan 20264:32 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSDividend Declaration
28th Jan 20265:18 pmRNSIssue of Equity
23rd Jan 202610:01 amRNSInvestor Presentation via Investor Meet Company
22nd Jan 20267:00 amRNSNet Asset Value and Portfolio Update
23rd Dec 20252:15 pmRNSQuarterly Report
23rd Dec 20252:15 pmRNSQuarterly Report
19th Dec 20257:00 amRNSNet Asset Value and Portfolio Update
17th Dec 20257:00 amRNSRecent Investment Announcement
9th Dec 20255:03 pmRNSManager Reinvestment in EJFI Shares
9th Dec 20254:50 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSNet Asset Value and Portfolio Update
20th Nov 20257:00 amRNSChange in Service Provider
31st Oct 20253:43 pmRNSTotal Voting Rights
30th Oct 20255:04 pmRNSIssue of Equity
29th Oct 20255:14 pmRNSIssue of Equity
29th Oct 20254:04 pmRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
23rd Oct 20257:00 amRNSDividend Declaration
21st Oct 20257:00 amRNSNet Asset Value and Portfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.